PRRT is typically administered in an outpatient setting. The process involves several steps:
1. Preparation: Patients may receive amino acid infusions to protect the kidneys. 2. Injection: The peptide-radionuclide compound is injected intravenously. 3. Monitoring: Patients are monitored for a few hours post-injection for any immediate side effects. 4. Follow-Up: Multiple cycles of PRRT are often required, spaced several weeks apart, and patients are monitored regularly to assess the therapy's effectiveness and manage any side effects.
